Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk estimation from somatic mutation assays

J A Heddle1, R R Swiger

  • 1Department of Biology, York University, Toronto, Ontario, Canada. jheddle@yorku.ca

Mutation Research
|September 1, 1996
PubMed
Summary

Quantifying somatic mutations in vivo offers toxicological insights for cancer risk assessment. Key factors influencing mutant frequency include age, expression time, and treatment protocols, crucial for accurate hazard evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New approaches to antimutagenesis.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer·2004
Same author

The influence of dietary flaxseed and other grains, fruits and vegetables on the frequency of spontaneous chromosomal damage in mice.

Mutation research·2004
Same author

Effect of dietary supplementation on the frequency of spontaneous lacZ mutations in the developing colon.

Mutation research·2004
Same author

Just how does the cII selection system work in Muta Mouse?

Environmental and molecular mutagenesis·2001
Same author

Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo.

Environmental and molecular mutagenesis·2001
Same author

A test of the mutagenicity of cooked meats in vivo.

Mutagenesis·2001

Area of Science:

  • Toxicology
  • Genetics
  • Cancer Research

Background:

  • Somatic mutations quantified in vivo provide novel toxicological data for cancer risk assessment.
  • Understanding factors influencing mutant frequency is essential for accurate risk evaluation.

Purpose of the Study:

  • To explore the utility of quantifying somatic mutations in vivo for toxicological assessment and cancer risk.
  • To identify and analyze experimental factors affecting mutant frequency.

Main Methods:

  • Utilizing transgenic assays to quantify somatic mutations in vivo.
  • Analyzing factors such as age, time after treatment (expression time), treatment protocol, and tissue type.
  • Comparing mutant frequencies across different tissues and treatment durations.

Main Results:

  • Mutant frequency increases with age, with varying rates from conception to adulthood.
  • Somatic tissues in adults generally show similar mutant frequencies.
  • Expression time is a critical variable, with minimum expression times varying by tissue.
  • Chronic treatment protocols are more effective for delivering higher doses and are preferable for dose extrapolations.

Conclusions:

  • Quantifying in vivo somatic mutations is a valuable tool for toxicological information and cancer risk assessment.
  • Accurate comparisons require understanding tissue-specific expression times.
  • Further research is needed on tissue-specific mutation frequencies and the role of transcription in mutation rates.

Related Experiment Videos